Your gut may be primed for peanut allergy before you ever eat one

A new study from UNC School of Medicine offers a surprising clue about why some children develop peanut allergies: the gut may already be in a vulnerable state before any allergen exposure. Published in Cellular and Molecular Gastroenterology and Hepatology, the research used single-cell RNA sequencing to map every cell type in the small intestinal lining of allergy-prone mice — and found a striking defect in Paneth cells, the gut's antimicrobial guardians.

Specifically, allergy-susceptible mice completely lacked expression of lysozyme 1 (Lyz1), a key antimicrobial enzyme produced by Paneth cells. Without it, the gut microbiome shifts toward bacteria that promote allergic immune responses, the gut barrier weakens, and immune cells that trigger allergic reactions ramp up. Crucially, the same pattern — fewer lysozyme-producing cells — was confirmed in small intestinal biopsies from pediatric peanut allergy patients.

Key Takeaways:

• The gut barrier defect appears before allergen exposure, suggesting allergy susceptibility is built in, not triggered
• Loss of a single protein (lysozyme) cascades into microbiome changes, immune skewing, and increased gut permeability
• Tuft cells — key initiators of allergic immune responses — were elevated and showed heightened expression of allergic receptors (IL-4Rα)

Why it matters: Peanut allergy affects ~2% of U.S. children and drives the majority of fatal food-induced anaphylaxis cases. Current treatments focus on avoidance and emergency epinephrine. This research reframes the question — from "how do we treat allergy?" to "can we prevent the gut from becoming susceptible in the first place?" — potentially enabling early intervention before a child's first allergic reaction.